Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Apr;117(7):1374–1376. doi: 10.1111/j.1476-5381.1996.tb15294.x

Functional evidence of atypical beta 3-adrenoceptors in the human colon using the beta 3-selective adrenoceptor antagonist, SR 59230A.

F De Ponti 1, G Gibelli 1, T Croci 1, M Arcidiaco 1, F Crema 1, L Manara 1
PMCID: PMC1909449  PMID: 8730727

Abstract

The role of beta 3-adrenoceptors in human colonic circular smooth muscle was assessed in vitro by use of the beta 3-selective antagonist SR 59230A. Isoprenaline, in the presence of the selective beta-adrenoceptor antagonists CGP 20712A (beta 1) and ICI 118551 (beta 2), both at 0.1 microM, concentration-dependently relaxed the preparation (pEC50 = 5.22). This effect was potently and competitively antagonized by SR 59230A with a pA2 of 8.31, while its R,R enantiomer SR 59483A gave an apparent pKB of 6.21. Relaxation was likewise produced by CGP 12177A (pEC50 = 6.05), but not by BRL 37344. Although only one of these beta 3-selective agonists was effective, the remarkably high potency of SR 59230A as a stereospecific antagonist of non-beta 1 non-beta 2 relaxation of human colonic muscle by isoprenaline provides strong functional evidence of beta 3-adrenoceptors in that tissue.

Full text

PDF
1374

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blin N., Nahmias C., Drumare M. F., Strosberg A. D. Mediation of most atypical effects by species homologues of the beta 3-adrenoceptor. Br J Pharmacol. 1994 Jul;112(3):911–919. doi: 10.1111/j.1476-5381.1994.tb13167.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Carpéné C., Castan I., Collon P., Galitzky J., Moratinos J., Lafontan M. Adrenergic lipolysis in guinea pig is not a beta 3-adrenergic response: comparison with human adipocytes. Am J Physiol. 1994 Mar;266(3 Pt 2):R905–R913. doi: 10.1152/ajpregu.1994.266.3.R905. [DOI] [PubMed] [Google Scholar]
  3. Granneman J. G., Lahners K. N., Chaudhry A. Characterization of the human beta 3-adrenergic receptor gene. Mol Pharmacol. 1993 Aug;44(2):264–270. [PubMed] [Google Scholar]
  4. Krief S., Lönnqvist F., Raimbault S., Baude B., Van Spronsen A., Arner P., Strosberg A. D., Ricquier D., Emorine L. J. Tissue distribution of beta 3-adrenergic receptor mRNA in man. J Clin Invest. 1993 Jan;91(1):344–349. doi: 10.1172/JCI116191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Liggett S. B. Functional properties of the rat and human beta 3-adrenergic receptors: differential agonist activation of recombinant receptors in Chinese hamster ovary cells. Mol Pharmacol. 1992 Oct;42(4):634–637. [PubMed] [Google Scholar]
  6. Manara L., Croci T., Landi M. Beta 3-adrenoceptors and intestinal motility. Fundam Clin Pharmacol. 1995;9(4):332–342. doi: 10.1111/j.1472-8206.1995.tb00507.x. [DOI] [PubMed] [Google Scholar]
  7. Thomas R. F., Liggett S. B. Lack of beta 3-adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human. Mol Pharmacol. 1993 Mar;43(3):343–348. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES